Open Source Biotechnology: A Drug for Developing Countries' Health Problems?

9 Pages Posted: 12 May 2008

See all articles by Maurice H.M. Schellekens

Maurice H.M. Schellekens

Tilburg University - Faculty of Law (TILT); Tilburg University - Tilburg Institute for Law, Technology, and Society (TILT)

Date Written: May 10, 2007

Abstract

In developing countries, many people suffer from diseases for which there are no drugs or for which drugs exist that they cannot afford because they are too expensive. The advent of genomics has sparked the idea that new drugs can be more easily developed and that genomics thus could lessen the health problems prevalent in developing countries. Until now, genomics has not been able to realise that promise. This paper explores whether, and if so, how open source biotechnology (hereinafter: OSB) can stimulate medical drug development specifically targeted at the health problems of developing countries.

Keywords: IPR, open source, biotechnology, innovation, developing countries

JEL Classification: K11, K32

Suggested Citation

Schellekens, Maurice H.M., Open Source Biotechnology: A Drug for Developing Countries' Health Problems? (May 10, 2007). Available at SSRN: https://ssrn.com/abstract=1130798 or http://dx.doi.org/10.2139/ssrn.1130798

Maurice H.M. Schellekens (Contact Author)

Tilburg University - Faculty of Law (TILT) ( email )

Tilburg, 5000 LE
Netherlands

Tilburg University - Tilburg Institute for Law, Technology, and Society (TILT) ( email )

P.O.Box 90153
Prof. Cobbenhagenlaan 221
Tilburg, 5037
Netherlands

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
216
Abstract Views
1,353
rank
179,966
PlumX Metrics